<DOC>
	<DOCNO>NCT00514449</DOCNO>
	<brief_summary>The purpose study examine whether antiviral medication help improve psychotic symptom cognition individual early course schizophrenia schizoaffective disorder expose herpes simplex virus , type 1 ( HSV 1 ) , virus cause commonly occur recurrent cold sore .</brief_summary>
	<brief_title>Systematic Evaluation Antiviral Medication Schizophrenia</brief_title>
	<detailed_description>The main objective study evaluate efficacy add-on treatment Valacyclovir ( VAV ) , antiviral medication , treatment early course schizophrenia/schizoaffective disorder patient . Our main hypothesis VAV add-on treatment improve positive , negative cognitive symptom herpes simplex virus ( HSV ) positive schizophrenia schizoaffective disorder patient . We hypothesize grey matter reduction specific brain region ( prefrontal region ) improve patient VAV + antipsychotic compare placebo + antipsychotic improvement positive , negative cognitive symptom correlate grey matter change .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Both gender age 1850 year Schizophrenia schizoaffective disorder define DSMIV Duration illness 10 year less On stable dose antipsychotic medication least month Should score 4 least one subscales PANSS Positive HSV1 Written inform consent Substance abuse last month/dependence 6 month prior study History , current medical/neurological illness affect CNS function e.g. , epilepsy , head injury prolong loss consciousness Pregnancy History immune disorder , HIV infection currently receive immunosuppressant Subjects regular antiviral therapy History hypersensitivity Valacyclovir Mental retardation define DSMIV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>